Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Amazon

Amazon closes $3.9B acquisition of One Medical

The closure of the deal comes after Amazon faced some backlash toward the acquisition, with some arguing the move gives the retailer too much power.

Thumbnail

Millions unaware they will lose Medicaid coverage when COVID-19 PHE ends

In a survey by the Robert Wood Johnson Foundation from December 2022, 64.3% of adults in Medicaid-enrolled families were unaware of the resumption of Medicaid renewals in the future.

AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

healthcare value value-based care money dollar

CMS testing 3 new ways to lower drug prices

“HHS is using every tool available to us to lower healthcare costs and increase access to high-quality, affordable healthcare,” says HHS Secretary Xavier Becerra.

Thumbnail

Florida cardiology practice, 10 cardiologists pay $2M to settle fraud allegations

The practice and many of its cardiologists allegedly submitted false claims to Medicare, Medicaid, TRICARE and the Federal Employee Health Benefits Program. 

HHS issues guidance as COVID-19 PHE winds down

The guidance clarifies what will and will not be impacted by the sunset of the PHE on May 11.

 

Thumbnail

Americans getting more and more dissatisfied with abortion policies

A record high of 69% of U.S. adults are dissatisfied with abortion laws––the highest percentage since 2001, according to a recent Gallup poll.

Thumbnail

Atrium Health and CEO indicted in $407M healthcare fraud scheme

The scheme allegedly included cheating employees, committing mail fraud, providing inadequate care to residents and more. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup